Back
Capricor Therapeutics Quote, Financials, Valuation and Earnings
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Buy
59
CAPR
Capricor Therapeutics
Last Price:
18.47
Seasonality Move:
15.69%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Capricor Therapeutics Price Quote
$18.47
+1.56 (+9.23%)
(Updated: November 14, 2024 at 5:55 PM ET)
Capricor Therapeutics Key Stats
Buy
59
Capricor Therapeutics (CAPR)
is a Buy
Day range:
$16.77 - $18.58
52-week range:
$2.80 - $23.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.95
P/B ratio:
51.2%
Volume:
1.7M
Avg. volume:
2.4M
1-year change:
495.42%
Market cap:
$589M
Revenue:
$25.2M
EPS:
$-0.89
How Much Does Capricor Therapeutics Make?
-
How Much Are Capricor Therapeutics's Sales Annually?
CAPR Revenues are $25.2M -
How Much Profit Does Capricor Therapeutics's Make A Year?
CAPR net income is -$22.3M
Is Capricor Therapeutics Growing As A Company?
-
What Is Capricor Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.01% -
What Is Capricor Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Capricor Therapeutics Stock Price Performance
-
Did Capricor Therapeutics Stock Go Up Last Month?
Capricor Therapeutics share price went down by -4.84% last month -
Did CAPR's Share Price Rise Over The Last Year?
CAPR share price rose by 495.42% over the past 1 year
What Is Capricor Therapeutics 52-Week High & Low?
-
What Is Capricor Therapeutics’s 52-Week High Share Price?
Capricor Therapeutics has traded as high as $23.40 over the past 52 weeks -
What Is Capricor Therapeutics’s 52-Week Low Share Price?
Capricor Therapeutics has traded as low as $2.80 over the past 52 weeks
Capricor Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Capricor Therapeutics?
-
How Much Debt Does Capricor Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Capricor Therapeutics Have?
Cash and short term investments quarterly total is $29.5M -
What Is Capricor Therapeutics’s Book Value Per Share?
Book value per share is 0.36
Is Capricor Therapeutics Cash Flow Positive?
-
What Is CAPR Cash Flow From Operations?
Cash flow from operations (TTM) is -$33.9M -
What Is Capricor Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $27.7M -
What Is Capricor Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $7.1M
Capricor Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CAPR return on invested capital is -261.27% -
What Is Capricor Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -60.85% -
What Is CAPR Return On Equity?
ROE is a measure of profitability and is -261.27%
Capricor Therapeutics Earnings Date & Stock Price
-
What Is Capricor Therapeutics's Stock Price Today?
A single share of CAPR can be purchased today for 16.91 -
What Is Capricor Therapeutics’s Stock Symbol?
Capricor Therapeutics trades on the nasdaq under the ticker symbol: CAPR -
When Is Capricor Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Capricor Therapeutics is scheduled on February 28, 2025 -
When Is CAPR's next ex-dividend date?
Capricor Therapeutics's next ex-dividend date is November 15, 2024 -
How To Buy Capricor Therapeutics Stock?
You can buy Capricor Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Capricor Therapeutics Competitors
-
Who Are Capricor Therapeutics's Competitors?
Below is a list of companies who compete with Capricor Therapeutics or are related in some way:
Capricor Therapeutics Dividend Yield
-
What Is CAPR Dividend Yield?
Capricor Therapeutics’s dividend yield currently is 0% -
What Is Capricor Therapeutics’s Payout Ratio?
Capricor Therapeutics’s payout ratio is 0% -
When Did Capricor Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Capricor Therapeutics’s Dividend Per Share?
Capricor Therapeutics pays a dividend of $0.00 per share
Capricor Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -5% |
| Revenue: | 1.38% | 8.39% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 40.67 |
| Upside from Last Price: | 140.49% |